DNA X, Inc. (SONM) stock
SONMNasdaqTelephone & Telegraph ApparatusFiscal year ends December 31
$2.17−0.21 (-8.82%)
Close on Nov 13, 2026Market cap $3.23MP/E –Yield –
Earnings
DNA X's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q1 FY2026
–
– on a year earlier
EPS, Q1 FY2026
$5.01
$0.08 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of DNA X's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | May 20, 2026during market hours | – | – | $5.01 | Release |
| Q4 FY2025ended Dec 31, 2025 | Apr 15, 2026after the close | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 31, 2025before the open | $16.20M | +8.0% | -$4.83 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 8, 2025during market hours | $11.20M | -2.6% | -$0.79 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 12, 2025during market hours | $16.72M | -0.5% | $0.08 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 31, 2025during market hours | $15.00M | +11.9% | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 13, 2024during market hours | $15.00M | -45.7% | -$0.52 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 9, 2024during market hours | $11.50M | -57.1% | -$1.41 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 14, 2024during market hours | $16.80M | -34.9% | -$0.07 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 27, 2024during market hours | $13.40M | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 14, 2023before the open | $27.60M | +34.6% | $0.01 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 17, 2023before the open | $26.80M | – | $0.01 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 25, 2023during market hours | $25.80M | +94.0% | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 14, 2022during market hours | $20.50M | +42.4% | -$0.04 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 10, 2022during market hours | $13.30M | – | -$0.38 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 12, 2021during market hours | $14.40M | – | -$1.31 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 16, 2021during market hours | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 11, 2021during market hours | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 11, 2021before the open | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 12, 2020before the open | – | – | – | Filing |
| Q1 FY2020ended Mar 31, 2020 | May 14, 2020during market hours | – | – | – | Filing |
| Q4 FY2019ended Dec 31, 2019 | Mar 11, 2020during market hours | – | – | – | Filing |
| Q3 FY2019ended Sep 30, 2019 | Oct 30, 2019before the open | – | – | – | Filing |
| Q2 FY2019ended Jun 30, 2019 | Jul 24, 2019during market hours | – | – | – | Filing |
| Q1 FY2019ended Mar 31, 2019 | Jun 24, 2019during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
DNA X has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When DNA X puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases DNA X filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- News
- Results
- Results
- Results
- Results
- Update
- Results
See a number that looks wrong?